来自MSN29 天
Eosinophilic AsthmaEosinophilic asthma (also known as e-asthma ... genetic and environmental factors likely play a role in its development. This type of asthma doesn't respond to traditional treatments, so other ...
Eosinophil Biology and Immune Regulation - Novel insights into eosinophil development, differentiation, and activation. - Crosstalk between eosinophils and other immune cells in autoimmune and ...
Areteia Therapeutics introduces dexpramipexole, a novel oral drug in Phase 3 trials for asthma and COPD, aiming for approval ...
The eosinophilic esophagitis market is steadily growing, driven by a higher awareness of the condition and improved diagnostic methods. An increase in the number of treatment options, particularly ...
Eosinophil-derived proteins including eosinophil secondary granule proteins (major ... We thank Shikha Sundaram, David Brumbaugh and Sean Colgan for their helpful comments on the manuscript ...
4 小时
Best Life on MSNStress Is Making You Itchy, Study Finds—Here's HowA new study supports the link between stress and itching. In the experiment, mice exposed to stress showed worse allergic skin reactions than those not made anxious. But even with a potential ...
A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time one of the allergens ...
Etrasimod is under clinical development by Pfizer and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase II drugs for Eosinophilic Esophagitis have an 80% phase ...
37 with a 7.4 fold increase in the risk of death from asthma if blood levels of eosinophils are raised. The development of airway wall remodelling is a characteristic feature of asthma that may result ...
Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and ...
Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...
Previously, it has been suggested that type-2 innate immune cells, particularly eosinophils and their production of IL-4, play an essential role in effective muscle regeneration after acute injury. We ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果